Cipla inks investment pact with FIL Capital Investment
No financial deals of the agreement were disclosed
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Merck plans to sell its allergy business unit to cut debt
The sale, which could fetch about $636.42 million, is an attempt by the company to offload its debt after the Sigma Aldrich Corp…
TAKE Solutions names Raman Kapur as Independent Director
US-based Raman Kapur brings pharma and generics expertise to TAKE board
TAKE Solutions announced the appointment of a new…
Sales rep files sexual harassment claims against DRL, Promius Pharma
The case was filed on July 31, 2015 and the nature of the suit is civil rights-employment
A woman sales representative from…
US FDA warns of serious data integrity violations at DRL
The US Food and Drug Administration has warned DRL over serious data integrity violations, placing all its new applications or…
Romaco Group acquires Medipac
Romaco Group’s decision to purchase the assets of Medipac will strengthen its position in the effervescents sector
Romaco Group…
DRL welcomes govt’s move on simplifying taxation laws
The company, however, wants deferment of sunset clause for SEZs
Dr Reddy's Laboratories (DRL) has welcomed the government's…
Delhi HC tells govt not to take coercive steps against pharma cos
Petitions were filed by pharma companies and an association of medicine manufacturing firms challenging the government's new drug…
Pfizer, IIT Delhi launch ‘Innovation & IP Program’
The programme will help to create healthcare innovations in India
Pfizer with IIT Delhi have announced the launch of ‘The Pfizer…
Lupin receives FDA approvals for generic loestrin tabs
The tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of…
DuPont to showcase health ingredients solutions at CPhI India 2015
An insightful technical presentation will be held on probiotics on December 2
DuPont, in collaboration with Indian distributor SA…
Wockhardt gets exemption from price control for three insulin products
The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013
Drug price regulator…
Mankind Pharma launches anti-diabetic product Dynaglipt
Zydus Cadila also launches its generic Tenglyn tablets, Gliptins, in the Indian market for Rs 7 per tablet
Mankind Pharma has…
NPPA gives drug cos final chance to register with pharma data bank
Failure to do so will invite penal action
NPPA has given a final chance to pharmaceutical companies to register themselves with…
Mylan acquires certain women healthcare businesses from Famy Care
To create a leading Women's Healthcare Franchise
Zigy to make quality diabetes care more accessible and affordable
Zigy aims to efficiently connect Indians needing healthcare products
Zigy, a first-of-its-kind patient-controlled electronic…
STEER develops B2C technology for pharma cos
STEERLife’s technology solutions are developed using six sigma framework and process analytics making it easily possible to…
Merck, University of Cape Town sign research agreement
To develop a drug discovery platform for malaria
Merck has signed a research agreement with University of Cape Town (UCT) South…
Cabinet nod to set up NARF at Genome Valley, Hyderabad
The institution will breed and house quality lab animals for basic and applied biomedical research in the country
Dr Reddy’s completes Fondaparinux IP purchase
The company had signed a term sheet for this transaction with its Australian partner, Alchemia in September 2015